Vimentin in cancer and its potential as a molecular target for cancer therapy

Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration

(2015)   Oncotarget

Salinomycin Selectively Targets ‘CD133+’ Cell Subpopulations and Decreases Malignant Traits in Colorectal Cancer Lines

(2011) Tao-Tao Dong et al.   ANNALS OF SURGICAL ONCOLOGY

Genetic Ablation of PKC Epsilon Inhibits Prostate Cancer Development and Metastasis in Transgenic Mouse Model of Prostate Adenocarcinoma

(2011) B. B. Hafeez et al.   CANCER RESEARCH

Discovery and Development of Therapeutic Aptamers

(2010) P.R. Bouchard et al.   Annual Review of Pharmacology and Toxicology

Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis

(2010) Hiroyuki Jin et al.   BIOMEDICAL RESEARCH-TOKYO

Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes

(2010) O. Ashiru et al.   CANCER RESEARCH

Filament-associated TSGA10 protein is expressed in professional antigen presenting cells and interacts with vimentin

(2010) Ali Roghanian et al.   CELLULAR IMMUNOLOGY

Anaplasma phagocytophilum AptA modulates Erk1/2 signalling

(2010) Bindu Sukumaran et al.   CELLULAR MICROBIOLOGY

Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces

(2010) Hirohiko Ise et al.   GLYCOBIOLOGY

A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis

(2010) Man Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm)

(2010) Stella Sun et al.   JOURNAL OF PROTEOME RESEARCH

Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release

(2010) Rattiyaporn Kanlaya et al.   Molecular BioSystems

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas

(2010) J Braun et al.   ONCOGENE

Vimentin is a novel AKT1 target mediating motility and invasion

(2010) Q-S Zhu et al.   ONCOGENE

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer

(2010) K Vuoriluoto et al.   ONCOGENE

Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas

(2010) Ali Bouamrani et al.   PLoS One

Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

(2010) Guy Lahat et al.   PLoS One

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

(2009) Kai-jie Wu et al.   ACTA PHARMACOLOGICA SINICA

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection

(2009) Xueping Zhang et al.   CLINICAL & EXPERIMENTAL METASTASIS

Leukocyte transmigration is modulated by chemokine-mediated PI3Kγ-dependent phosphorylation of vimentin

(2009) Laura Barberis et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Vimentin Inhibits ATF4-mediatedOsteocalcinTranscription and Osteoblast Differentiation

(2009) Na Lian et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recruitment of vimentin to the cell surface by  3 integrin and plectin mediates adhesion strength

(2009) R. Bhattacharya et al.   JOURNAL OF CELL SCIENCE

An Appraisal of Intermediate Filament Expression in Adult and Developing Pancreas: Vimentin Is Expressed in α Cells of Rat and Mouse Embryos

(2009) Alessandro Di Bella et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Vimentin Regulates Scribble Activity by Protecting It from Proteasomal Degradation

(2009) Dominic C.Y. Phua et al.   MOLECULAR BIOLOGY OF THE CELL

Inhibition of vimentin or  1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo

(2009) X. Zhang et al.   MOLECULAR CANCER THERAPEUTICS

Glycoproteomic Analysis of Human Lung Adenocarcinomas Using Glycoarrays and Tandem Mass Spectrometry: Differential Expression and Glycosylation Patterns of Vimentin and Fetuin A Isoforms

(2009) Jung-Hyun Rho et al.   PROTEIN JOURNAL

Identification of pancreatic cancer invasion-related proteins by proteomic analysis

(2009) Naomi Walsh et al.   Proteome Science

Endosomal lipid accumulation in NPC1 leads to inhibition of PKC, hypophosphorylation of vimentin and Rab9 entrapment

(2008) Marc Walter et al.   BIOLOGY OF THE CELL

Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference

(2008) Chen Liu et al.   BMC CANCER

Galectin-1 Is Implicated in the Protein Kinase C ε/Vimentin-Controlled Trafficking of Integrin-β1 in Glioblastoma Cells

(2008) Shannon Fortin et al.   BRAIN PATHOLOGY

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

(2008) S Al-Saad et al.   BRITISH JOURNAL OF CANCER

Vimentin affects the mobility and invasiveness of prostate cancer cells

(2008) Yan Zhao et al.   CELL BIOCHEMISTRY AND FUNCTION

Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice

(2008) R. P. Singh et al.   CLINICAL CANCER RESEARCH

NF-κB and epithelial to mesenchymal transition of cancer

(2008) Chengyin Min et al.   JOURNAL OF CELLULAR BIOCHEMISTRY